Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Joan Ramon Garces Gatnau
40 years of experience
Clinic is certified :
Psoriasis treatment cost in Spain typically involves a complex diagnosis of dermatological disease ranging from $200 to $400. While specific surgical procedures are uncommon, total annual management costs run from $1,100 for mild cases to over $18,000 for advanced biologic therapies. Prices depend on disease severity, medication type, and clinic tier. Patients can save approximately 30-50% compared to the US. Top cities include Barcelona and Madrid.
Typical Psoriasis Treatment Costs in Spain
Bookimed Expert Insight: Patients with complex or refractive psoriasis benefit most from JCI-accredited multidisciplinary centers. Clinica Universidad de Navarra, ranked among the World's Best Hospitals, serves over 140,000 international patients. For those seeking advanced research-based care, Quironsalud Madrid provides access to clinical trials. Barcelona's Centro Médico Teknon offers premium diagnostic services utilized by high-profile professional athletes. These top-tier Spanish hospitals provide significant value for patients requiring long-term biological therapy monitoring.
The doctor is a specialist in Medical-Surgical Dermatology with over 45 years of experience. As the Clinical Head of Dermatology at Hospital de Sant Pau and Director of the Mohs Unit at the Autonomous University of Barcelona, the doctor has pioneered in the field of oncodermatology.
With expertise in Skin Cancer Prevention, Diagnosis, and Treatment, the doctor has performed over 1,400–2,000 Mohs Micrographic Surgery procedures, achieving cure rates higher than traditional methods. The doctor is also skilled in Photodynamic Therapy, Skin Cancer Screening, and STI management.
The doctor is a member of several prestigious societies and holds an average rating of 4.9/5 on TopDoctors and 9.9/10 on AiroMedical.
The doctor is a pediatric oncologist with 37 years of experience, specializing in the treatment of blood disorders and performing procedures like bone marrow transplants and ablation therapy. The doctor is currently the Head of Paediatric Haemato-Oncology at Quironsalud Madrid University Hospital.
With a prolific academic record, the doctor has edited 14 books, contributed to 75 book chapters, and presented at over 200 conferences. The doctor is a member of several professional associations, including the Spanish Association of Paediatric Haematology and the Spanish Association of Paediatric Oncology.
The doctor treats a wide range of conditions, including leukemia, lymphoma, multiple myeloma, and various hematological and autoimmune disorders.
The doctor heads the Department of Urology and kidney transplantation at Teknon Medical Center in Barcelona, Spain, with over 30 years of experience. Specializing in uro-oncology and transplantology, the doctor has overseen more than 500 successful operations, focusing on pathologies of the urogenital system using minimally invasive methods, including laparoscopic and robotic-assisted surgeries.
The doctor is particularly noted for expertise in prostate cancer treatment and utilizes the Da Vinci robotic system for innovative surgical procedures. Additionally, the doctor treats congenital pathologies in children such as cryptorchism and is a member of the American Urological Confederation, Urological Association of Spain, and European Urological Society.
The doctor is a distinguished neurologist specializing in epilepsy, currently leading the epilepsy department at HM Delfos Hospital in Spain. With a PhD from Bonn University and a specialization in neurology from Pontificia Universidad Católica de Chile, the doctor has extensive experience in treating neurological disorders.
As a professor at UPF University, the doctor has contributed significantly to the field through research and publications on topics such as cognitive impairments in Alzheimer patients and drug-resistant epilepsy. The doctor is actively involved in professional organizations like SEN and the European Reference Network.
Advanced psoriasis treatments in Spain feature biological therapies, targeted oral small molecules, and localized excimer lasers. Specialists at JCI-accredited centers utilize IL-23 and IL-17 inhibitors for long-term skin clearance. These therapies follow European Medicines Agency regulations to ensure high safety standards and clinical efficacy.
Bookimed Expert Insight: Spain ranks 6th globally for medical tourism, attracting over 1,100 patients annually through our platform. Clinics like Clinica Universidad de Navarra maintain top Newsweek rankings by integrating research and biological trials. Patients should prioritize centers with JCI accreditation, as these facilities report high volumes, like Centro Médico Teknon with 23,500 operations yearly.
Patient Consensus: Patients note that biologics often deliver clear skin after topical treatments fail. Many emphasize the importance of bringing detailed symptom photos to specialists to ensure disease severity is correctly assessed.
Spain offers high-quality psoriasis care at JCI-accredited hospitals in Madrid and Barcelona. These centers provide advanced biologic therapies and phototherapy. Leading facilities like Centro Médico Teknon and Hospital Universitario Quirónsalud Madrid utilize multidisciplinary teams to manage systemic symptoms and psoriatic arthritis effectively.
Bookimed Expert Insight: Patient volume is a major indicator of chronic disease expertise in Spain. Hospital HM Nou Delfos treats 400,000 patients annually. Large networks like HM Hospitales or Clínica Universidad de Navarra often have better access to specialized phototherapy equipment. Private centers are ideal for rapid diagnostic starts. However, complex biologics are most efficiently managed at academic centers with high patient turnover.
Patient Consensus: Patients note it is vital to find a medical dermatologist rather than a cosmetic specialist. Many suggest using large teaching hospitals for easier access to modern phototherapy and ongoing systemic treatment monitoring.
Spain's climate improves psoriasis symptoms through natural phototherapy and favorable humidity. High UVB levels in regions like the Canary Islands slow skin cell turnover. Coastal air prevents skin from cracking. Many patients achieve temporary remission during summer months due to better skin barrier function.
Bookimed Expert Insight: Spain ranks sixth globally for medical travel on Bookimed, largely due to high-capacity centers like Clinica Universidad de Navarra serving 700,000 international patients. While the climate is a major benefit, these JCI-accredited facilities provide the advanced diagnostic foundation, such as complex immunograms, needed to stabilize symptoms before patients begin natural sun therapy.
Patient Consensus: Many patients find that warm, sunny days significantly reduce their flares, though they emphasize that results vary. Most note that coastal air feels gentler on the skin, but they still rely on daily moisturizing to maintain their progress.
International patients and tourists can access advanced psoriasis treatment via Spain's private healthcare sector. Specialized clinics in Barcelona and Madrid offer phototherapy, excimer lasers, and biologic agents. Private facilities provide shorter wait times and multilingual support for medical travelers with JCI-accredited standards.
Bookimed Expert Insight: Spain ranks 6th globally in medical tourism volume. Large networks like HM Hospitals and Quironsalud manage massive patient flows, with Clinica Universidad de Navarra alone treating 140,000 yearly. This high volume enables these centers to frequently participate in clinical trials for refractory psoriasis cases.
Patient Consensus: Patients note that private care is the only realistic route for short-term visitors. They recommend bringing physical photos of past prescriptions and prior diagnosis records to speed up specialist evaluations.